NEW YORK (GenomeWeb News) – Denator and two Dutch medical centers today announced a collaboration to develop a biomarker discovery platform for the diagnosis of cancer.

Denator, based in Gothenburg, Sweden, is working with Erasmus Medical Center and Amsterdam Medical Center to develop and verify a prototype platform for monitoring specific protein and peptide degradation patterns in biological fluids and tissue sections. Denator is applying its heat stabilization technology to the project, which is being funded by the EU Eurostars program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.